Radioiodine: The classic theranostic agent

Seminars in Nuclear Medicine

Volumn 42, Issue 3, 2012, Pages 164-170

  Silberstein, Edward B ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE; IODINE 123; IODINE 124; IODINE 125; IODINE 131;

ARTICLE; CAMERA; CANCER PATIENT; CELL HETEROGENEITY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DOSIMETRY; GOITER; HALF LIFE TIME; HYPOXIA; PARATHYROID SCINTISCANNING; POSITRON EMISSION TOMOGRAPHY; SEAWEED; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THYROID CANCER; THYROID DISEASE; THYROTOXICOSIS; WAR;

EID: 84859316607     PISSN: 00012998     EISSN: 15584623     Source Type: Journal    
DOI: 10.1053/j.semnuclmed.2011.12.002     Document Type: Review

References (57)

1. D.Y. Lee, C.P. King Molecular theranostics: A primer for the imaging professional Am J Roentgenol 197 2011 318 324
2. T. Lammers, S. Aime, W.E. Hennink Theranostic nanomedicine Acc Chem Res 44 2011 1029 1038
3. S. Del Vecchio, A. Zannetti, R. Fonti Nuclear imaging in cancer theranostics Q J Nucl Med Mol Imaging 51 2007 152 163
4. E. Fermi Radioactivity induced by neutron bombardment Nature 122 1934 201
5. C.T. Sawin, D.V. Becker Radioiodine and the treatment of hyperthyroidism: The early history Thyroid 7 1997 163 176
6. W.H. Beierwaltes, H.N. Wagner, L. Vought The thyroid gland H.N. Wagner, Principles of Nuclear Medicine 1968 WB Saunders Philadelphia, PA
7. C.P. Leblond The time dimension in cell biology FASEB J 9 1995 1234
8. S. Hertz, A. Roberts, R.D. Evans Radioactive iodine as an indicator in the study of thyroid physiology Proc Soc Exp Biol Med 38 1938 510 513
9. S. Hertz, A. Roberts, R.D. Evans Radioactive iodine as an indicator in thyroid physiology: Iodine collection by normal and hyperplastic thyroids in rabbits Am J Physiol 128 1940 565 569
10. S. Hertz, A. Roberts Radioactive iodine as an indicator in thyroid physiology Endocrinologist 29 1941 82 85
11. J.G. Hamilton, M.H. Soley Studies in iodine metabolism by the use of a new radioactive isotope of iodine Am J Physiol 131 1940 135 141
12. S. Hertz, A. Roberts Application of radioactive iodine in therapy of Graves' disease J Clin Invest 21 1942 624 (abstract)
13. J.G. Hamilton, J.H. Lawrence Recent clinical developments n the therapeutic applications of radio-phosphorus and radio-iodine J Clin Invest 21 1942 624 (abstract)
14. S. Hertz, A. Roberts Radioactive iodine in the study of thyroid physiology VII. The use of radioactive iodine therapy in hyperthyroidism JAMA 131 1946 81 86
15. E.M. Chapman, R.D. Evans The treatment of hyperthyroidism with radioactive iodine JAMA 131 1946 86 91
16. W.G. Pollard Availability of radioactive isotopes Science 103 1946 697
17. N.B. Myant, E.E. Pochin, E.A. Goldie The plasma iodide clearance rate of the human thyroid Clin Sci 8 1949 109 115
18. J.H. Nodine, B.J. Channick, D. Sokhos Measurement of the active iodine stores and daily hormonal output of the intact human thyroid J Clin Endocrinol Metab 17 1957 832 838
19. D.E. Clark, R.H. Moe, E.E. Adams The rate of conversion of administered inorganic radioactive iodine into proten-bound iodine of plasma as an aid in the evaluation of thyroid function Surgery 26 1949 331 337
20. S.M. Seidlin, L.D. Marinelli, E. Oshry Radioactive iodine therapy: Effect on functioning metastases of adenocarcinoma of the thyroid JAMA 132 1946 838 847
21. B. Cassen, L. Curtis Measurement of ionizing radiations in vivo Science 110 1949 94 95
22. H.O. Anger Use of a gamma-ray pinhole camera for in vivo studies Nature 170 1952 200 201
23. W.G. Myers, J.C. Vanderleeden Radioiodine-125 J Nucl Med 1 1960 149 164
24. H.R. Maxon, S.R. Thomas, R.C. Samaratunga Dosimetric considerations in the radioiodine treatment of macrometastases and micrometastases from differentiated thyroid cancer Thyroid 7 1997 183 187
25. 99m Tc Eur J Nucl Med 4 1979 37 41
26. N.D. Charkes, D.M. Sklaroff The use of iodine-125 in thyroid scintiscanning Am J Roentgenol 90 1963 1052 1058
27. 132 I J Nucl Med 10 1969 286 292
28. 132 I Radiol Diagn (Berl) 7 1966 347 352
29. W.G. Myers, H.O. Anger Iodine-123 J Nucl Med 3 1962 183
30. 131 I in thyroid disease J Nucl Med 15 1974 261 265
31. 131 I in thyroid diagnosis Semin Nucl Med 1 1971 356 378
32. G.L. DeNardo Will short-lived radionuclides come of age? Diagn Imaging 4 2 1982 68
33. H.N. Wagner, B.A. Rhodes The radiopharmaceutical H.N. Wagner, Principles of Nuclear Medicine 1968 WB Saunders Co Philadelphia, PA 279
34. S.Y. Wu, R.E. Weiss Radioiodine imaging in the primary care of thyroid disease Postgrad Med 119 2006 70 77
35. 123 I radiopharmaceuticals J Nucl Med 26 1985 936 940
36. 86 Y]yttrium Eur J Nucl Med Mol Imaging 38 suppl 1 2011 S4 S9
37. 86 Y with PET Eur J Nucl Med Mol Imaging 38 suppl 1 2011 S10 S18
38. I.R. McDougall, A. Iagaru Thyroid stunning: Fact or fiction? Semin Nucl Med 41 2011 105 112
39. 131 I pre-ablation imaging before radioiodine ablation in differentiated thyroid carcinoma J Nucl Med 48 2007 1043 1046
40. R.M. Tuttle, R. Leboeuf, R.J. Robbins Empiric radioactive iodine dosing regimens frequently exceed maximum tolerated activity levels in elderly patients with thyroid cancer J Nucl Med 47 2006 1587 1591
41. K. Kulkarni, D. Van Nostrand, F. Atkins The relative frequency in which empiric dosages of radioiodine would potentially overtreat or undertreat patients who have metastatic well-differentiated thyroid cancer Thyroid 16 2006 1019 1023
42. 131 I SPECT/CT Am J Roentgenol 195 2010 730 736
43. K.K. Wong, N. Zarzhevsky, J.M. Cahill Incremental value of diagnostic 131I SPECT/CT fusion imaging in the evaluation of differentiated thyroid carcinoma Am J Roentgenol 191 2008 1785 1794
44. 123 I for thyroid imaging Am J Roentgenol Radium Ther Nucl Med 117 1973 195 201
45. P.V. Harper, R. Beck, D. Charleston Optimization of a scanning method using Tc-99m Nucleonics 22 1964 50 54
46. W.H. Beierwaltes The treatment of thyroid carcinoma with radioactive iodine Semin Nucl Med 8 1978 79 94
47. A. Bockisch Matched pairs for radionuclide-based imaging and therapy Eur J Nucl Med Mol Imaging 38 suppl 1 2011 S1 S3
48. H.R. Maxon, S.R. Thomas, V.S. Hertzberg Relation between effective radiation dose and outcome of radioiodine therapy for thyroid cancer N Engl J Med 309 1983 937 941
49. M.E. O'Connell, M.A. Flower, P.J. Hinton Radiation dose assessment in radioiodine therapy Dose response relationships in differentiated thyroid-carcinoma using quantitative scanning and PET Radiother Oncol 28 1993 16 26
50. G.D. Flux, M. Haq, S.J. Chittenden A dose-effect correlation for radioiodine ablation in differentiated thyroid cancer Eur J Nucl Med Mol Imaging 37 2010 270 275
51. S.M. Eschmann, G. Reischl, K. Bilger Evaluation of dosimetry of radioiodine therapy in benign and malignant thyroid disorders by means of iodine-124 and PET Eur J Nucl Med 29 2002 760 767
52. M.H. Michalski, X. Chen Molecular imaging in cancer treatment Eur J Nucl Med Mol Imaging 38 2011 358 377
53. B. Brans, L. Bodei, F. Giammarile Clinical radionuclide therapy dosimetry: The quest for the "Holy Gray" Eur J Nucl Med Mol Imaging 34 2007 772 786
54. M.W. Konijnenberg, M. de Jong Preclinical animal research on therapy dosimetry with dual isotopes Eur J Nucl Med Mol Imaging 38 suppl 1 2011 S19 S27
55. R.S. Benua, N.R. Cicale, M. Sonenberg The relation of radioiodine dosmetry to results and complications in the treatment of metastatic thyroid cancer Am J Roentgenol 87 1962 171 177
56. M.G. Stabin, R.M. Sharkey, J.A. Siegel RADAR commentary: Evolution and current status of dosimetry in nuclear medicine J Nucl Med 52 2011 1156 1160
57. P. Ritt, H. Vija, J. Hornegger Absolute quantification with SPECT Eur J Nucl Med Mol Imaging 38 suppl 1 2011 S69 S77